|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
N/A |
Shares
Out: |
26,519,000 |
Market
Cap: |
19.62(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.4192 - $0.92 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile VolitionRx is an epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
102,500 |
466,136 |
1,061,784 |
1,262,206 |
Total Buy Value |
$48,375 |
$248,375 |
$603,875 |
$798,637 |
Total People Bought |
3 |
3 |
4 |
12 |
Total Buy Transactions |
4 |
6 |
11 |
31 |
Total Shares Sold |
0 |
0 |
0 |
40,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$33,000 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
2 |
End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Plummer Nicholas |
GC - Volition Diagnostics |
|
2025-07-01 |
4 |
D |
$0.77 |
$4,160 |
D/D |
(5,417) |
188,297 |
|
- |
|
Batchelor Ann-Louise |
Group Chief Marketing Officer |
|
2025-07-01 |
4 |
D |
$0.77 |
$4,743 |
D/D |
(6,177) |
141,106 |
|
- |
|
Butera Salvatore Thomas |
CEO - Volition Veterinary |
|
2025-07-01 |
4 |
D |
$0.77 |
$3,426 |
D/D |
(4,462) |
309,917 |
|
- |
|
Retter Andrew |
Chief Medical Officer |
|
2025-07-01 |
4 |
D |
$0.77 |
$3,380 |
D/D |
(4,401) |
137,774 |
|
- |
|
Rootsaert Rodney Gerard |
Secretary |
|
2025-07-01 |
4 |
D |
$0.77 |
$2,354 |
D/D |
(3,066) |
138,289 |
|
- |
|
Reynolds Cameron John |
President and CEO |
|
2025-06-12 |
4 |
B |
$0.59 |
$7,373 |
D/D |
12,500 |
2,331,722 |
0.01 |
- |
|
Innes Guy Archibald |
|
|
2025-06-03 |
4 |
B |
$0.54 |
$10,772 |
D/D |
20,000 |
888,689 |
0.01 |
- |
|
Forterre Gael |
Chief Commercial Officer |
|
2025-06-01 |
4 |
D |
$0.77 |
$1,533 |
D/D |
(1,996) |
159,466 |
|
- |
|
Butera Salvatore Thomas |
CEO, Volition Veterinary |
|
2025-06-01 |
4 |
D |
$0.50 |
$5,877 |
D/D |
(11,683) |
314,379 |
|
- |
|
Butera Salvatore Thomas |
CEO, Volition Veterinary |
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,377 |
326,062 |
|
- |
|
Rubin Ethel |
|
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,983 |
45,524 |
|
- |
|
Retter Andrew |
Chief Medical Officer |
|
2025-06-01 |
4 |
D |
$0.50 |
$2,313 |
D/D |
(4,598) |
142,175 |
|
- |
|
Retter Andrew |
Chief Medical Officer |
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,069 |
146,773 |
|
- |
|
Gaetan Michel |
Chief Operating Officer |
|
2025-06-01 |
4 |
D |
$0.50 |
$3,941 |
D/D |
(7,835) |
380,441 |
|
- |
|
Hughes Terig |
Chief Financial Officer |
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,406 |
407,627 |
|
- |
|
Forterre Gael |
Chief Commercial Officer |
|
2025-06-01 |
4 |
D |
$0.50 |
$2,130 |
D/D |
(4,234) |
161,462 |
|
- |
|
Forterre Gael |
Chief Commercial Officer |
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,690 |
165,696 |
|
- |
|
Batchelor Ann-Louise |
Group Chief Marketing Officer |
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,341 |
147,283 |
|
- |
|
Nguyen Kim |
|
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,983 |
98,392 |
|
- |
|
Plummer Nicholas |
GC, Volition Diagnostics |
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,086 |
193,714 |
|
- |
|
Rootsaert Rodney Gerard |
Secretary |
|
2025-06-01 |
4 |
D |
$0.50 |
$3,223 |
D/D |
(6,408) |
141,355 |
|
- |
|
Rootsaert Rodney Gerard |
Secretary |
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,190 |
147,763 |
|
- |
|
Kway Jasmine |
CEO - Singapore Volition |
|
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,327 |
191,107 |
|
- |
|
Micallef Jacob Vincent |
Chief Scientific Officer |
|
2025-06-01 |
4 |
D |
$0.50 |
$10,828 |
D/D |
(21,526) |
404,507 |
|
- |
|
Reynolds Cameron John |
President and CEO |
|
2025-05-19 |
4 |
B |
$0.44 |
$8,730 |
D/D |
20,000 |
2,319,222 |
0.01 |
- |
|
409 Records found
|
|
Page 1 of 17 |
|
|